Toxoplasmosis medical therapy: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(3 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Toxoplasmosis}}
{{Toxoplasmosis}}


{{CMG}}{{AE}}
{{CMG}} ;{{AE}} {{ADG}}
==Overveiw==
==Overveiw==
Treatment of immunocompetent adults with lymphadenopathic toxoplasmosis is rarely indicated. Treatment for ocular diseases should be based on a complete ophthalmologic evaluation.When a pregnant woman is diagnosed with acute toxoplasmosis, amniocentesis can be used to determine whether the fetus has been infected or not.If the parasite has not yet reached the fetus, [[spiramycin]] can help to prevent placental transmission. If the fetus has been infected, the pregnant woman can be treated with [[pyrimethamine]] and [[sulfadiazine]], with [[folinic acid]], after the first trimester. Persons with AIDS who develop active toxoplasmosis (usually toxoplasmic enchephalitis) need treatment that must be taken until a significant immunologic improvement is achieved as a result of antiretroviral therapy.
Treatment of immunocompetent adults with lymphadenopathic toxoplasmosis is rarely indicated. Treatment for ocular diseases should be based on a complete ophthalmologic evaluation.When a pregnant woman is diagnosed with acute toxoplasmosis, amniocentesis can be used to determine whether the fetus has been infected or not.If the parasite has not yet reached the fetus, [[spiramycin]] can help to prevent placental transmission. If the fetus has been infected, the pregnant woman can be treated with [[pyrimethamine]] and [[sulfadiazine]], with [[folinic acid]], after the first trimester. Persons with AIDS who develop active toxoplasmosis (usually toxoplasmic enchephalitis) need treatment that must be taken until a significant immunologic improvement is achieved as a result of antiretroviral therapy.
Line 68: Line 68:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Infectious disease]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Neurosurgery]]
[[Category:Neurosurgery]]
Line 81: Line 79:
[[Category:Zoonoses]]
[[Category:Zoonoses]]
[[Category:Parasitic diseases]]
[[Category:Parasitic diseases]]
[[Category:Needs overview]]
[[Category:Needs overview]]
[[Category:Emergency mdicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]

Latest revision as of 00:26, 30 July 2020

Toxoplasmosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxoplasmosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxoplasmosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxoplasmosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxoplasmosis medical therapy

CDC on Toxoplasmosis medical therapy

Toxoplasmosis medical therapy in the news

Blogs on Toxoplasmosis medical therapy

Directions to Hospitals Treating Toxoplasmosis

Risk calculators and risk factors for Toxoplasmosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overveiw

Treatment of immunocompetent adults with lymphadenopathic toxoplasmosis is rarely indicated. Treatment for ocular diseases should be based on a complete ophthalmologic evaluation.When a pregnant woman is diagnosed with acute toxoplasmosis, amniocentesis can be used to determine whether the fetus has been infected or not.If the parasite has not yet reached the fetus, spiramycin can help to prevent placental transmission. If the fetus has been infected, the pregnant woman can be treated with pyrimethamine and sulfadiazine, with folinic acid, after the first trimester. Persons with AIDS who develop active toxoplasmosis (usually toxoplasmic enchephalitis) need treatment that must be taken until a significant immunologic improvement is achieved as a result of antiretroviral therapy.

Medical Therapy

Treatment of immunocompetent adults with lymphadenopathic toxoplasmosis is rarely indicated. Treatment for ocular diseases should be based on a complete ophthalmologic evaluation.When a pregnant woman is diagnosed with acute toxoplasmosis, amniocentesis can be used to determine whether the fetus has been infected or not.If the parasite has not yet reached the fetus, spiramycin can help to prevent placental transmission. If the fetus has been infected, the pregnant woman can be treated with pyrimethamine and sulfadiazine, with folinic acid, after the first trimester. Persons with AIDS who develop active toxoplasmosis (usually toxoplasmic enchephalitis) need treatment that must be taken until a significant immunologic improvement is achieved as a result of antiretroviral therapy.

Antimicrobial Regimen

  • Toxoplasma gondii (treatment)
  • 1. Lymphadenopathic toxoplasmosis[1]
  • Preferred regimen: Treatment of immunocompetent adults with lymphadenopathic toxoplasmosis is rarely indicated; this form of the disease is usually self-limited.
  • 2. Ocular disease[2]
  • 2.1 Adults
  • *1. Pathogen-directed antimicrobial therapy[3]
  • Preferred regimen: Pyrimethamine 200 mg PO qd on day 1 then 50-75 mg PO qd for 2 weeks beyond resolution of symptoms AND Sulfadiazine 1-1.5 g PO qid for 2 weeks beyond resolution of symptoms AND Leucovorin (Folinic acid) 5-20 mg PO 3 times/week for 3 weeks beyond resolution of symptoms
  • 2.2 Pediatric
  • Preferred regimen: Pyrimethamine 2 mg/kg PO first day then 1 mg/kg each day AND Sulfadiazine 50 mg/kg PO bid AND folinic acid (Leucovorin 7.5 mg/day PO ) for 4 to 6 weeks followed by reevaluation of the patient's condition
  • Alternative regimen: The fixed combination of Trimethoprim with Sulfamethoxazole has been used as an alternative.
  • Note: If the patient has a hypersensitivity reaction to sulfa drugs, Pyrimethamine AND Clindamycin can be used instead.
  • 3. Maternal and fetal infection[4]
  • 3.1 First and early second trimesters
  • 3.2 Late second and third trimesters
  • 3.3 Infant
  • 4. Toxoplasma gondii Encephalitis in AIDS[5]
  • 4.1 Treatment for acute infection
  • 4.2 Chronic maintenance therapy
  • Preferred regimen: Pyrimethamine 25–50 mg PO qd AND sulfadiazine 2000–4000 mg PO qd (in 2–4 divided doses) AND Leucovorin 10–25 mg PO qd
  • Alternative regimen (1): Clindamycin 600 mg PO q8h AND (Pyrimethamine 25–50 mg AND Leucovorin 10–25 mg) PO qd
  • Alternative regimen (2): TMP-SMX DS 1 tablet bid
  • Alternative regimen (3): Atovaquone 750–1500 mg PO bid AND (Pyrimethamine 25 mg AND Leucovorin 10 mg) PO qd
  • Alternative regimen (4): Atovaquone 750–1500 mg PO bid
  • Alternative regimen (5): Sulfadiazine 2000–4000 mg PO bid/qid
  • Alternative regimen (6): Atovaquone 750–1500 mg PO bid Pyrimethamine and Leucovorin doses are the same as for preferred therapy
  • Note: Adjunctive corticosteroids (e.g., Dexamethasone) should only be administered when clinically indicated to treat mass effect associated with focal lesions or associated edema; discontinue as soon as clinically feasible. Anticonvulsants should be administered to patients with a history of seizures and continued through acute treatment, but should not be used as seizure prophylaxis . If Clindamycin is used in place of Sulfadiazine, additional therapy must be added to prevent PCP.
  • Toxoplasma gondii (prophylaxis)
  • 1. Prophylaxis to prevent first episode of encephalitis in AIDS[6]
  • 1.1 Indications
  • Toxoplasma IgG-positive patients with CD4 count <100 cells/µL
  • Seronegative patients receiving PCP prophylaxis not active against toxoplasmosis should have toxoplasma serology retested if CD4 count decline to <100 cells/µL. Prophylaxis should be initiated if seroconversion occurred.
  • 1.2 Prophylactic therapy

References

  1. "Parasites - Toxoplasmosis (Toxoplasma infection)".
  2. "Parasites - Toxoplasmosis (Toxoplasma infection)".
  3. Montoya JG, Liesenfeld O (2004). "Toxoplasmosis". Lancet. 363 (9425): 1965–76. doi:10.1016/S0140-6736(04)16412-X. PMID 15194258.
  4. "Parasites - Toxoplasmosis (Toxoplasma infection)".
  5. "Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents" (PDF).
  6. "Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents" (PDF).


Template:WikiDoc Sources